Category: Access to Breakthroughs

May 4, 2020

Alliance Submits Comments to U.S. Food & Drug Administration Regarding the Inclusion of Older Adults in Cancer Clinical Trials

On Monday, May 4, 2020, the Alliance submitted feedback to the FDA in response to a request for comments on…
March 17, 2020

Alliance for Aging Research Suggests Improvements to ClinicalTrials.gov

The National Library of Medicine (NLM), the world’s largest biomedical library and part of the National Institutes of Health, solicited…
May 5, 2017

Five Reasons You Should Participate in Clinical Trials

Clinical trials play a significant role in medical research and without volunteers, there would be no way to discover new cures or medical breakthroughs. We’ve compiled a list of the top 5 reasons you should participate in a clinical trial!
May 4, 2017

New Pocket Film to Encourage Clinical Trial Participation

We’re excited to announce that we have a new film that highlights the importance of clinical trials and why people should participate in them!
May 3, 2017

New Educational Film Pay It Forward: Volunteering for a Clinical Trial Encourages Clinical Trial Enrollment

In honor of Clinical Trials Awareness Week, the Alliance for Aging Research (Alliance) has released a new animated “pocket film,” Pay it Forward: Volunteering for a Clinical Trial, to encourage clinical trial volunteerism. 
February 22, 2017

First-Ever Heart Valve Disease Awareness Day Puts Condition in National Spotlight

The first-ever National Heart Valve Disease Awareness Day is being celebrated throughout the country today, as organizations, advocates, and individuals join together to increase recognition about the risks of heart valve disease (HVD) and improve detection and treatment access to ultimately save lives.
February 10, 2017

Letter to HHS Secretary Tom Price on Maintaining and Enforcing Important Patient Protections and Access to Prescription Drugs

The Alliance joined with 200 other organizations to call on Secretary of Health and Human Services Tom Price in his review of the Patient Protection and Affordable Care Act "to maintain the many important protections patients have gained that ensure they can access the care and treatment their providers prescribe."  
January 24, 2017

Comments on Oversight Framework for Molecular Diagnostic Tests, including Laboratory Developed Tests (LDTs)/Senate Version

This letter to Senate Majority Leader Sen. Mitch McConnell and Senate Minority Leader Sen. Charles Schumer that urges them to "make updating the oversight framework for all molecular diagnostic tests, including laboratory developed tests (LDTs), a priority early in the 115th Congress." 
January 24, 2017

Comments on Oversight Framework for Molecular Diagnostic Tests, including Laboratory Developed Tests (LDTs)/House Version

This letter to House Speaker Rep. Paul Ryan and House Minority Speaker Rep. Nancy Pelosi urges them to "make updating the oversight framework for all molecular diagnostic tests, including laboratory developed tests (LDTs), a priority early in the 115th Congress."
December 7, 2016

Alliance Releases Statement on Passage of 21st Century Cures

The Senate today approved landmark legislation overhauling the development of medical treatments and cures for patients, which represents the culmination of a multi-year, bipartisan initiative in Congress. Here is a statement from Alliance President and CEO Sue Peschin.